[Clinical implications of the new immunologic classification of the hemolytic anemias with autoantibodies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000145:classification* / Q000188:drug therapy / Q000209:etiology; D001323:Autoantibodies / Q000145:classification*; D002648:Child; D003168:Complement Fixation Tests; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D008875:Middle Aged; D008258:Waldenstrom Macroglobulinemia / Q000150:complications
D001323:Autoantibodies; D005938:Glucocorticoids
Implications cliniques de la nouvelle classification immunologique des anémies hémolytiques avec auto-anticorps.